Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00887627
What this trial is testing

Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney Function

Who this might be right for
Kidney DiseasesHyponatremia
Cumberland Pharmaceuticals 25
Large-scale testing (Phase 3)Study completedNCT02865850
What this trial is testing

Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Participants With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)

Who this might be right for
AnemiaDialysis-Dependent Chronic Kidney Disease
Akebia Therapeutics 369
Large-scale testing (Phase 3)Study completedNCT02504294
What this trial is testing

A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis

Who this might be right for
Chronic Kidney Disease (CKD)
Pfizer 432
Not applicableStudy completedNCT02087566
What this trial is testing

Linezolid Pharmacokinetics In Patients With Impaired Renal Function (PPT6)

Who this might be right for
Renal FailureImpaired Renal Function
Damanhour University 18
Large-scale testing (Phase 3)Study completedNCT00497146
What this trial is testing

The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4

Who this might be right for
Chronic Kidney DiseaseLeft Ventricular Hypertrophy
AbbVie (prior sponsor, Abbott) 227
Large-scale testing (Phase 3)Study completedNCT00506441
What this trial is testing

A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia

Who this might be right for
Chronic Kidney DiseaseDialysisHyperphosphatemia
Tanabe Pharma Corporation 245
Large-scale testing (Phase 3)Study completedNCT02879305
What this trial is testing

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)

Who this might be right for
AnaemiaAspergillosis, Allergic Bronchopulmonary
GlaxoSmithKline 2,964
Early research (Phase 1)Study completedNCT02248051
What this trial is testing

Open-Label Safety, Tolerability, PK Study of IV CXA-10 Emulsion in Subjects in Chronic Kidney Injury

Who this might be right for
Acute Kidney Injury (Nontraumatic)
Complexa, Inc. 12
Early research (Phase 1)Study completedNCT02320045
What this trial is testing

Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects

Who this might be right for
Renal Insufficiency
Intarcia Therapeutics 38
Early research (Phase 1)Study completedNCT02108639
What this trial is testing

To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 41
Early research (Phase 1)Study completedNCT00791401
What this trial is testing

The Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal Function

Who this might be right for
SchizophreniaRenal Impairment
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Not applicableStudy completedNCT05827588
What this trial is testing

Late Feasibility Study to Evaluate Safety and Efficacy of AWAK PD Device in Subjects With ESKD.

Who this might be right for
Chronic Kidney Diseases
AWAK Technologies Pte Ltd 12
Large-scale testing (Phase 3)Study completedNCT00443690
What this trial is testing

Placebo-Controlled Randomized Study of KW-3902 for Subjects Hospitalized With Worsening Renal Function and Heart Failure Requiring IV Therapy

Who this might be right for
Heart Failure, Congestive
NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 480
Testing effectiveness (Phase 2)Ended earlyNCT00787618
What this trial is testing

Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females

Who this might be right for
Renal Impairment
Repros Therapeutics Inc. 6
Large-scale testing (Phase 3)Study completedNCT02827708
What this trial is testing

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 324
Early research (Phase 1)Study completedNCT01759576
What this trial is testing

Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Volunteers With Varying Degrees of Kidney Function

Who this might be right for
Renal InsufficiencyHealthy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40
Early research (Phase 1)Study completedNCT02135276
What this trial is testing

A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects

Who this might be right for
End Stage Renal Disease
Tetraphase Pharmaceuticals, Inc 12
Post-approval studies (Phase 4)Study completedNCT00632125
What this trial is testing

Post-authorization Safety Study in CKD Subjects Receiving HX575 i.v.

Who this might be right for
Chronic Kidney Disease
Sandoz 1,695
Early research (Phase 1)Study completedNCT06911320
What this trial is testing

Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function

Who this might be right for
Healthy Volunteer StudyHepatic ImpairmentRenal Impairment
Atea Pharmaceuticals, Inc. 28
Not applicableEnded earlyNCT02196610
What this trial is testing

Feasibility Study of Arterial Stiffness in Hemodialysis Patients

Who this might be right for
End-Stage Renal Disease
Ottawa Hospital Research Institute 36
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation